2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Acute coronary syndromes (ACS) are a comprehensive disease concept characterized by
acute myocardial ischemia caused by disruption of coronary artery plaque and consequent …

Background Current guidelines recommend potent platelet inhibition with ticagrelor or
prasugrel in patients after an acute coronary syndrome. However, data about optimal …

Coronary artery disease (CAD) is a major cause of morbidity and mortality in patients≥ 80
years of age. Nonetheless, older patients have typically been under-represented in …

Background Elderly patients are at high risk of ischaemic and bleeding events. Platelet
function monitoring offers the possibility to individualise antiplatelet therapy to improve the …

Diagnostic and therapeutic advances during the past decades have substantially improved
health outcomes for patients with acute coronary syndrome. Both age-related physiological …

Background: In patients presenting with ST-segment–elevation myocardial infarction,
percutaneous coronary intervention (PCI) reduces mortality when compared with fibrinolysis …

Background Previous trials suggest lower long-term risk of mortality after invasive rather
than non-invasive management of patients with non-ST elevation myocardial infarction …

Importance To our knowledge, no randomized clinical trial has compared the invasive and
conservative strategies in frail, older patients with non–ST-segment elevation acute …

Coronary artery disease (CAD) is highly prevalent in older adults, yet its management
remains challenging. Treatment choices are made complex by the frailty burden of older …